RESUBMITTED NDA FOR ANTICANCER AGENT HALAVEN® ACCEPTED IN CHINA ... Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced ...
確定! 回上一頁